Immunophotonics
Pre-clinicalImmunophotonics' proprietary glycan polymer enhances antigen capture & immune processes, unlocking platform potential for immunotherapy.
Founded
2010
Focus
Vaccines
About
Immunophotonics' proprietary glycan polymer enhances antigen capture & immune processes, unlocking platform potential for immunotherapy.
Funding History
3Total raised: $37M
Series B$25MRiverVest Venture PartnersMar 15, 2022
Series A$10MBioGeneratorMay 15, 2019
Grant$2MNational Cancer InstituteJun 15, 2017
Company Info
TypePrivate
Founded2010
LocationSt. Louis, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile